Login / Signup

Correction: A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).

Shin KobayashiMasafumi IkedaKohei NakachiMakoto UenoTakuji OkusakaAkiko TodakaSohei SatoiAkira TomokuniMasaru KonishiJunji Furuse
Published in: Annals of surgical oncology (2023)
Keyphrases
  • phase iii
  • double blind
  • open label
  • clinical trial
  • papillary thyroid
  • phase ii
  • cross sectional
  • placebo controlled
  • squamous cell
  • lymph node
  • study protocol
  • randomized controlled trial
  • childhood cancer